Condition
Berberine
Total Trials
5
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (3)
P 4 (2)
Trial Status
Completed3
Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07480018Not ApplicableRecruitingPrimary
Berberine Supplementation, Sprint Interval Training, and Immune Function Study
NCT06703086Not ApplicableCompleted
Gene Modulation of NLRP3, IL-1β and TNF-α in Peripheral Blood of Patients With Exogenous Obesity Treated With Berberine
NCT03708549Phase 4Unknown
Comparison of Berberine and Metformin for the Treatment for MS in Schizophrenia Patients
NCT04932070Not ApplicableCompleted
Berberine and Polycystic Ovary Syndrome
NCT04479202Phase 4CompletedPrimary
The Effect of Berberine on Intestinal Function and Inflammatory Mediators in Severe Patients With Covid-19
Showing all 5 trials